MAP-4 antibody
Principal name
MAP-4 antibody
Alternative names for MAP-4 antibody
Microtubule-associated protein 4, MAP4
Ncbi ID
9606, NP_001127836.1, NM_002375, NP_001192259.1, BC042645, NM_008633, NM_001024278, NM_030885
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Immunocytochemistry/Immunofluorescence (ICC/IF), Paraffin Sections (P)
Background of MAP-4 antibody
- Kit Component:
- - KN309743G1, Map4 gRNA vector 1 in pCas-Guide vector
- KN309743G2, Map4 gRNA vector 2 in pCas-Guide vector
- KN309743D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Human Jurkat; WB Suggested Anti-MAP4 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: Jurkat cell lysate; MAP4 antibody - N-terminal region (ARP60314_P050) in Human Jurkat cells using Western Blot
Predicted cell location: Cytoplasm . Positive control: Human ovarian and lung cancer tissue . Recommended dilution: 1/15-50 The image on the left is immunohistochemistry of paraffin-embedded human ovarian cancer tissue using MAP4 antibody at dilution 1/10, on the right is treated with the fusion protein. (Original magnification:x 200)
Predicted cell location: Cytoplasm . Positive control: Human ovarian and lung cancer tissue . Recommended dilution: 1/15-50 The image on the left is immunohistochemistry of paraffin-embedded human lung cancer tissue using MAP4 antibody at dilution 1/10, on the right is treated with the fusion protein. (Original magnification:x200)
Predicted cell location: Cytoplasm . Positive control: Human ovarian and thyroid cancer tissue . Recommended dilution: 1/15-50 The image on the left is immunohistochemistry of paraffin-embedded human ovarian cancer tissue using MAP4 antibody at dilution 1/10, on the right is treated with the fusion protein. (Original magnification:x 200)
Predicted cell location: Cytoplasm . Positive control: Human ovarian and thyroid cancer tissue . Recommended dilution: 1/15-50 The image on the left is immunohistochemistry of paraffin-embedded human thyroid cancer tissue using MAP4 antibody at dilution 1/10, on the right is treated with the fusion protein. (Original magnification:x200)
WB Suggested Anti-MAP4 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:312500; Positive Control: Jurkat cell lysate
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA323852 | MAP-4 antibody |
||||||
| Anti-MAP4 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
| TA323853 | MAP-4 antibody |
||||||
| Anti-MAP4 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR211666L2V | Lenti ORF particles, Map4 (GFP-tagged) - Mouse microtubule-associated protein 4 (Mtap4), transcript variant 2, 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€1,890.00
|
|
| OriGene Technologies, Inc. | ||
| MR211666L1V | Lenti ORF particles, Map4 (Myc-DDK-tagged) - Mouse microtubule-associated protein 4 (Mtap4), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,700.00
|
|
| OriGene Technologies, Inc. | ||
| MR211020L2V | Lenti ORF particles, Mtap4 (GFP-tagged) - Mouse microtubule-associated protein 4 (cDNA clone MGC:38678 IMAGE:5357023), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,470.00
|
|
| OriGene Technologies, Inc. | ||
| MR211020L1V | Lenti ORF particles, Mtap4 (Myc-DDK-tagged) - Mouse microtubule-associated protein 4 (cDNA clone MGC:38678 IMAGE:5357023), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,330.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR206233L2V | Lenti ORF particles, Map4 (GFP-tagged ORF) - Rat microtubule-associated protein 4 (Map4), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,330.00
|
|
| OriGene Technologies, Inc. | ||
| RR206233L1V | Lenti ORF particles, Map4 (Myc-DDK-tagged ORF) - Rat microtubule-associated protein 4 (Map4), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,110.00
|
|
| OriGene Technologies, Inc. | ||